Teva’s strategy: What will it hold, what will it let go?

Teva CEO Jeremy Levin's strategic plan for Teva will be fateful for a string of Israeli biomed development companies.

By GALI WEINREB
December 9, 2012 23:53
Teva Pharmaceutical plant is seen in Jerusalem

Teva 311. (photo credit: REUTERS/Ronen Zvulun)


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Israel Weather
  • 15 - 27
    Beer Sheva
    18 - 23
    Tel Aviv - Yafo
  • 15 - 23
    Jerusalem
    16 - 22
    Haifa
  • 20 - 36
    Elat
    18 - 28
    Tiberias